
Bioorganic and Medicinal Chemistry Letters p. 2241 - 2246 (1998)
Update date:2022-08-05
Topics:
Sakaki, Junichi
Murata, Toshiki
Yuumoto, Yoko
Nakamura, Ikushi
Frueh, Thomas
Pitterna, Thomas
Iwasaki, Genji
Oda, Kyoko
Yamamura, Takaki
Hayakawa, Kenji
IRL 3461, N-butanesulfonyl-[N-(3,5-dimethylbenzoyl)-N-methyl-3-[4-(5- isoxazolyl)-phenyl]-alanyl]-(L)-valineamide, a potent and bifunctional (ET(A) + ET(B)) [Ki(ET(A))=1.8 nM, Ki(ET(B))=1.2 nM] antagonist was discovered by structural modification of IRL 2500, an ET(B) selective antagonist. IRL 3461 was found to be stable on incubation with human, rat, mouse, and guinea pig plasmas.
View MoreNIGNXIA XINDACHANG TECHNOLOGY CO.,LTD
Contact:86-0951-7815345
Address:North side of Qiyuan Road, west side of Yuanfeng Highway, New Material Park, Ningdong Energy and Chemical Industry Base, Ningxia,China
Contact:852-27701081
Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
Contact:86-551-63540590
Address:No 1388 Furong Rd., Hefei, Anhui, China
Contact:+86-134-5286-9121
Address:Add: Wing Tuck Commercial Centre, 177-183 Wing Lok Street, Hong Kong,
Contact:86+21-56421993
Address:3F,BUILDING 10,NO.2889 JINKE ROAD, SHANGHAI.
Doi:10.1016/S0040-4039(96)02032-1
(1996)Doi:10.1021/jo961168z
(1997)Doi:10.1016/S0040-4020(99)00444-5
(1999)Doi:10.1002/anie.201703174
(2017)Doi:10.1016/j.tet.2016.08.001
(2016)Doi:10.1139/v96-244
(1996)